Piramal Pharma Limited has appointed Mr. Amit Soni as an Independent Director, effective February 9, 2026, for a term of five consecutive years, subject to shareholder approval. Mr. Soni, with DIN: 05111144, is a Non-Executive Director and is not liable to retire by rotation. The appointment is based on the recommendation of the Nomination and Remuneration Committee.
Independent Director Appointment
Piramal Pharma Limited has announced the appointment of Mr. Amit Soni as an Independent Director to their board. This appointment is scheduled to take effect on February 9, 2026, and will continue for a term of five consecutive years, pending shareholder approval.
Key Details of Appointment
Based on the announcement, Mr. Soni will serve as a Non-Executive, Independent Director. He bears the Director Identification Number (DIN): 05111144. The decision to appoint Mr. Soni follows a recommendation from the Nomination and Remuneration Committee, ensuring a thorough and compliant selection process.
Mr. Soni’s Background
Prior to joining Piramal Pharma, Mr. Soni was a Partner at CVC Capital. He has over two decades of experience partnering with founders, management teams, business families and the Government. He also spent 9 years with General Atlantic. Mr. Soni holds an MBA from The Wharton School and a Bachelor of Technology degree in Electrical Engineering from IIT Delhi.
Source: BSE
